Clinical Trial Update: Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase I study in healthy volunteers to evaluate the tolerability of the eye drop DA-6034 for dry eye syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• DA-6034

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Dry Eye Syndrome | Phase 1 | Status: COMPLETED